Skip to content

Role of vein puncture in varicose veins

Randomized controlled clinical study to evaluate the effect of siravedha in the management of siraj granthi w.s.r. to varicose veins

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/053114
Enrollment
40
Registered
2023-05-24
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I838- Varicose veins of lower extremities with other complications

Interventions

None listed

Sponsors

Dr Ishudhi Tyagi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 patient aged between 18-60 years of either sex 2 patient diagnosed with Nava sirajagranthi in lower limb only 3 patient fit for siravedha 4 patient with hb% between 12 to 16 gm/dl in males and 11 to 14 gm/ dl in females

Exclusion criteria

Exclusion criteria: 1 Presence of any tumor as a cause of varicose veins 2 Ulcers due to varicosity 3 Avalvulia or other congenital disorders 4 Blood clotting disorders 5 Patient on prolonged anti coagulant drugs 6 Children less than 18 or elderly above 60 years 7 Patient not willing for siravedha 8 Patient having history or suffering from TB uncontrolled hypertension anemia obesity uncontrolled diabetes mellitus chronic liver disease psychiatric patient carcinoma immune compromised (HIV and HBsAg positive cases)

Design outcomes

Primary

MeasureTime frame
The effect of siravedha will be evaluated , so as to eliminate the stagnant blood in tortuous veins.Timepoint: 8 weeks The siravedha will be given for 2 months(every week for 8 consecutive weeks)with lifestyle modification and elastic compression stockings follow up 1 month after completion of study

Secondary

MeasureTime frame
Relief in state of sarvang raktadushti , highly effective in improving hypoxia in varicose veins blood causing subsequent change in the quality of life of patientsTimepoint: After analysing all parameters the result will be assessed on the basis of symptomatic relief and improvement Fair recovery after 4 weeks improvement in clinical features 30 to 60 percent Good recovery improvement after 6 weeks improvement in clinical features 61 to 90 percent Complete recovery after 8 weeks improvement in clinical features more than 90 percent

Countries

India

Contacts

Public ContactDr Anjaneyulu Annaluru

Vaidya Yagya Dutt Sharma Ayurved Mahavidyalaya khurja Bulandshahr

anjaneyulu.annaluru@gmail.com9705042070

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026